# FDA Inspection 876725 - Henry A Frazer, Pharm D, Clinical Investigator - April 03, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/henry-a-frazer-pharm-d-clinical-investigator/f747817d-a636-4166-94e8-d7305c9df732/
Source feed: FDA_Inspections

> FDA Inspection 876725 for Henry A Frazer, Pharm D, Clinical Investigator on April 03, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 876725
- Company Name: Henry A Frazer, Pharm D, Clinical Investigator
- Inspection Date: 2014-04-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 803391 - 2012-10-03](https://www.globalkeysolutions.net/api/records/fda_inspections/henry-a-frazer-pharm-d-clinical-investigator/2a752939-7168-4229-aea1-36efc7826cb9/)
- [FDA Inspection 581025 - 2009-05-14](https://www.globalkeysolutions.net/api/records/fda_inspections/henry-a-frazer-pharm-d-clinical-investigator/033ea3d1-a32c-45db-b77e-b6b7e8e169e3/)

Company: https://www.globalkeysolutions.net/companies/henry-a-frazer-pharm-d-clinical-investigator/fa133beb-9211-4d24-8cd7-13ee5eaca54a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c